摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(2-thiophen-2-yl-phenylmethanesulfinyl)-acetamide

中文名称
——
中文别名
——
英文名称
2-(2-thiophen-2-yl-phenylmethanesulfinyl)-acetamide
英文别名
2-(2-(Thiophen-2-yl)benzylsulfinyl)acetamide;2-[(2-thiophen-2-ylphenyl)methylsulfinyl]acetamide
2-(2-thiophen-2-yl-phenylmethanesulfinyl)-acetamide化学式
CAS
——
化学式
C13H13NO2S2
mdl
——
分子量
279.384
InChiKey
ASHLPVRZZNGLGJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    18
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.15
  • 拓扑面积:
    108
  • 氢给体数:
    1
  • 氢受体数:
    4

反应信息

  • 作为产物:
    描述:
    (2-iodo-benzylsulfanyl)-acetic acid 在 四(三苯基膦)钯氯化亚砜双氧水 、 sodium carbonate 、 溶剂黄146 作用下, 以 乙醇甲苯 为溶剂, 反应 5.5h, 生成 2-(2-thiophen-2-yl-phenylmethanesulfinyl)-acetamide
    参考文献:
    名称:
    Aryl-Heteroaryl Derivatives as Novel Wake-Promoting Agents
    摘要:
    In search of a next generation molecule to the novel wake‐promoting agent modafinil, a series of aryl‐heteroayl‐derived wakefulness enhancing agents (in rats) was developed. From this work, compound 16 was separated into its enantiomers to profile them individually.
    DOI:
    10.1111/cbdd.12083
点击查看最新优质反应信息

文献信息

  • Biaryl-methanethio-, -sulphinyl- and sulphonyl derivatives
    申请人:CEPHALON, INC.
    公开号:EP1586559A1
    公开(公告)日:2005-10-19
    FIELD OF THE INVENTION The present invention is related to chemical compositions, processes for the preparation thereof and uses of the composition. Particularly, the present invention relates to compositions that include substituted biaryl-methanesulfinyl acetamides of Formula (I): wherein Ar, Y, R1, R2, R4, R5, q and x are as defined herein; and their use in the treatment of diseases, including treatment of sleepiness associated with narcolepsy, obstructive sleep apnea, or shift work disorder; Parkinson's disease; Alzheimer's disease; attention deficit disorder; attention deficit hyperactivity disorder; depression; or fatigue associated with a neurological disease; as well as the promotion of wakefulness.
    本发明涉及化学组合物、其制备方法以及组合物的用途。特别是,本发明涉及包括式(I)的取代联苯基-甲磺酰基乙酰胺的组合物: 其中Ar、Y、R1、R2、R4、R5、q和x如本文所定义;以及它们在治疗疾病中的用途,包括治疗与嗜睡症、阻塞性睡眠呼吸暂停或倒班工作障碍相关的嗜睡症、帕金森病、阿尔茨海默病、注意力缺陷障碍、注意力缺陷多动障碍、抑郁症或与神经系统疾病相关的疲劳,以及促进清醒。
  • Thio-substituted biaryl-methanesulfinyl derivatives
    申请人:Bacon R. Edward
    公开号:US20050245747A1
    公开(公告)日:2005-11-03
    The present invention is related to chemical compositions, processes for the preparation thereof and uses of the composition. Particularly, the present invention relates to compositions that include substituted biaryl-methanesulfinyl acetamides of Formula (I): wherein Ar, Y, R 1 , R 2 , R 4 , R 5 , q and x are as defined herein; and their use in the treatment of diseases, including treatment of sleepiness associated with narcolepsy, obstructive sleep apnea, or shift work disorder; Parkinson's disease; Alzheimer's disease; attention deficit disorder; attention deficit hyperactivity disorder; depression; or fatigue associated with a neurological disease; as well as the promotion of wakefulness.
    本发明涉及化学组合物,其制备过程和组合物的用途。特别是,本发明涉及包括式(I)的取代双芳基甲烷磺酰基乙酰胺的组合物: 其中,Ar,Y,R1,R2,R4,R5,q和x如本文所定义的;以及它们在治疗疾病方面的应用,包括治疗与嗜睡症、阻塞性睡眠呼吸暂停或倒班工作障碍有关的嗜睡症状,帕金森病,阿尔茨海默病,注意力缺陷障碍,注意力缺陷/多动障碍,抑郁症或与神经系统疾病有关的疲劳,以及促进清醒。
  • Thio-Substituted Biarylmethanesulfinyl Derivatives
    申请人:Bacon Edward R.
    公开号:US20090062284A1
    公开(公告)日:2009-03-05
    The present invention is related to chemical compositions, processes for the preparation thereof and uses of the composition. Particularly, the present invention relates to compositions that include substituted biaryl-methanesulfinyl acetamides of Formula (I): wherein Ar, Y, R 1 , R 2 , R 4 , R 5 , q and x are as defined herein; and their use in the treatment of diseases, including treatment of sleepiness associated with narcolepsy, obstructive sleep apnea, or shift work disorder; Parkinson's disease; Alzheimer's disease; attention deficit disorder; attention deficit hyperactivity disorder; depression; or fatigue associated with a neurological disease; as well as the promotion of wakefulness.
    本发明涉及化学成分、其制备过程和成分的用途。特别地,本发明涉及包括式(I)中的取代的双芳基甲烷磺酰乙酰胺的组合物:其中Ar、Y、R1、R2、R4、R5、q和x如本文中所定义的;以及它们在治疗疾病中的应用,包括治疗与纳考雷普西、阻塞性睡眠呼吸暂停或轮班工作障碍相关的嗜睡症;帕金森病;阿尔茨海默病;注意力缺陷障碍;注意力缺陷多动障碍;抑郁症;或与神经疾病相关的疲劳,以及促进清醒。
  • THIO-SUBSTITUTED BIARYL-METHANESULFINYL DERIVATIVES
    申请人:CEPHALON, INC.
    公开号:EP1737815A1
    公开(公告)日:2007-01-03
  • US7449481B2
    申请人:——
    公开号:US7449481B2
    公开(公告)日:2008-11-11
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐